Gene Expression Signature Connectivity Mapping for Hyperpigmentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for treating skin hyperpigmentation disorders are limited by the complexity of skin pigmentation processes and the difficulty in identifying effective and safe skin-lightening agents, particularly due to the diffuse and systemic nature of cosmetic conditions, which challenges conventional connectivity mapping approaches.

Innovation Solution

A novel connectivity mapping approach that utilizes keratinocyte cells to generate gene-expression profiles for developing a data architecture that identifies relationships between skin conditions and skin-active agents, allowing for the discovery of effective skin tone modifiers without requiring detailed knowledge of biological mechanisms or cell types associated with the condition.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional connectivity mapping approaches are used to identify skin-lightening agents, then the method is simple and straightforward, but the effectiveness is limited due to the diffuse and systemic nature of cosmetic conditions

Engineering Contradiction:
Improveeffectiveness of identifying skin-lightening agentsVSAvoidcomplexity of connectivity mapping approach
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent segments the complex skin pigmentation process into distinct gene expression profiles and cellular pathways. By breaking down the diffuse cosmetic condition into specific gene expression signatures and molecular targets, the method enables precise identification of skin-lightening agents through targeted connectivity mapping rather than relying on broad, ineffective conventional approaches

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces gene expression profiles as an intermediary layer between the cosmetic condition (hyperpigmentation) and the skin-lightening agents. This intermediary enables the connection between the diffuse systemic nature of cosmetic conditions and specific molecular targets, allowing effective agent identification through the mediating role of transcriptomic data

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If detailed knowledge of biological mechanisms and cell types is required to identify effective skin tone modifiers, then the identification process becomes more precise, but the complexity and time required increases significantly

Engineering Contradiction:
Improveprecision in identifying skin-active agentsVSAvoidtime required for identification process
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent performs preliminary actions by pre-generating comprehensive gene expression profiles from multiple cell types and comparing them to identify skin-active agents. This preliminary connectivity mapping creates a reference database that can be queried later without requiring detailed biological knowledge at the time of agent identification, thus reducing time loss while maintaining precision

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The method enables self-service identification where the gene expression data and connectivity maps serve as self-explanatory guides for identifying skin-active agents. The systematic organization of gene expression profiles and their relationships to skin tone modification allows researchers to identify effective agents through data-driven insights rather than requiring extensive prior knowledge of complex biological mechanisms

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS10468120B2Method of generating a hyperpigmentation condition gene expression signature
Publication Date: 2019.11.05 PROCTER & GAMBLE CO
  • US10468120B2 patent drawing
  • US10468120B2 patent drawing
  • US10468120B2 patent drawing

AI summary

A method of generating a hyperpigmentation condition gene expression signature for use in identifying connections between perturbagens and genes associated with a skin pigmentation condition. The method includes providing a gene expression profile for a reference sample of human skin cells not affected with a pigmentation condition; generating a gene expression profile for a sample of human skin cells from a subject exhibiting the hyperpigmentation condition; comparing the expression profiles to determine a gene expression signature that includes a set of differentially expressed genes; assigning an identifier to each gene constituting the gene expression signature and ordering the identifiers according to the direction of differential expression to create one or more gene expression signature lists; and storing the one or more gene expression signature lists on at least one computer readable medium.